Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedFeb 26, 2026
DataAggregated Company Financials
Companies5
  • 7D-1.3%
  • 3M-13.0%
  • 1Y-5.6%
  • YTD-10.2%

Over the last 7 days, the Biotech industry has dropped 1.3%, driven by Zealand Pharma declining 9.3%. However, the industry is down 5.6% over the past year. As for the next few years, earnings are forecast to decline by 2.0% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 26 Feb 2026DKK 154.0bDKK 39.7bDKK 14.9b6.2x10.3x3.9x
Sat, 24 Jan 2026DKK 177.3bDKK 40.5bDKK 18.9b6.3x9.4x4.4x
Mon, 22 Dec 2025DKK 175.5bDKK 40.6bDKK 19.0b6.1x9.2x4.3x
Wed, 19 Nov 2025DKK 168.0bDKK 40.9bDKK 19.1b5.8x8.8x4.1x
Fri, 17 Oct 2025DKK 185.5bDKK 38.9bDKK 16.8b13.2x11.1x4.8x
Sun, 14 Sep 2025DKK 158.8bDKK 38.8bDKK 16.7b12.7x9.5x4.1x
Tue, 12 Aug 2025DKK 126.0bDKK 29.8bDKK 8.9b11.7x14.2x4.2x
Thu, 10 Jul 2025DKK 124.6bDKK 26.9bDKK 7.3b11x17.1x4.6x
Sat, 07 Jun 2025DKK 137.5bDKK 27.5bDKK 7.5b11.3x18.3x5x
Mon, 05 May 2025DKK 136.0bDKK 27.3bDKK 7.7b11.9x17.7x5x
Wed, 02 Apr 2025DKK 128.5bDKK 27.3bDKK 7.7b11.3x16.7x4.7x
Fri, 28 Feb 2025DKK 165.7bDKK 27.7bDKK 7.8b12.5x21.2x6x
Sun, 26 Jan 2025DKK 166.7bDKK 26.0bDKK 4.7b17.1x35.5x6.4x
Tue, 24 Dec 2024DKK 160.6bDKK 26.0bDKK 4.7b16.6x34.2x6.2x
Thu, 21 Nov 2024DKK 157.9bDKK 26.0bDKK 4.7b16.5x33.5x6.1x
Sat, 19 Oct 2024DKK 174.2bDKK 25.5bDKK 5.5b21x31.8x6.8x
Mon, 16 Sep 2024DKK 199.3bDKK 25.5bDKK 5.5b23.8x36.4x7.8x
Wed, 14 Aug 2024DKK 195.5bDKK 26.0bDKK 5.7b18.2x34.3x7.5x
Fri, 12 Jul 2024DKK 194.6bDKK 24.8bDKK 5.6b17.6x34.6x7.8x
Sun, 09 Jun 2024DKK 179.2bDKK 24.8bDKK 5.6b18.5x31.8x7.2x
Tue, 07 May 2024DKK 181.6bDKK 25.2bDKK 6.2b16.1x29.5x7.2x
Thu, 04 Apr 2024DKK 186.7bDKK 23.9bDKK 5.0b19.6x37.1x7.8x
Sat, 02 Mar 2024DKK 184.8bDKK 22.8bDKK 4.3b23.5x43.2x8.1x
Mon, 29 Jan 2024DKK 167.0bDKK 23.3bDKK 4.2b22.9x40.1x7.2x
Wed, 27 Dec 2023DKK 175.3bDKK 23.3bDKK 4.2b25.7x42.1x7.5x
Fri, 24 Nov 2023DKK 171.6bDKK 23.3bDKK 4.2b24.5x41.2x7.4x
Sun, 22 Oct 2023DKK 162.9bDKK 22.0bDKK 4.7b18.9x34.4x7.4x
Tue, 19 Sep 2023DKK 199.5bDKK 22.0bDKK 4.7b23.1x42.1x9.1x
Thu, 17 Aug 2023DKK 190.1bDKK 20.6bDKK 3.9b36.5x49.1x9.2x
Sat, 15 Jul 2023DKK 200.5bDKK 19.5bDKK 4.4b40.9x45.5x10.3x
Mon, 12 Jun 2023DKK 206.9bDKK 19.5bDKK 4.4b43.5x47x10.6x
Wed, 10 May 2023DKK 203.7bDKK 17.9bDKK 4.1b31.8x49.7x11.4x
Fri, 07 Apr 2023DKK 199.2bDKK 17.9bDKK 3.5b31x56.3x11.1x
Sun, 05 Mar 2023DKK 197.5bDKK 17.9bDKK 3.5b30.4x55.7x11x
Price to Earnings Ratio

55.7x


Total Market Cap: DKK 197.5bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 31x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.3x which is lower than its 3-year average PE of 31.0x.
  • The 3-year average PS ratio of 7.0x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 61% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-9.10%
Healthcare-18.19%
Biotech-1.32%
Biotech-1.32%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.83k0.4%
+DKK 406.6m		13.3%PE18.5x
BAVA Bavarian NordicDKK 196.950.5%
+DKK 77.5m		14.4%PE6.2x

Latest News

ZEAL
DKK 359.50
Zealand Pharma
7D
-9.3%
1Y
-48.6%

ZEAL: Positive Immunology Data And Metabolic Partnership Will Support Future Upside

Analysts have trimmed their price target on Zealand Pharma by DKK 5 to reflect updated assumptions for revenue growth, profit margins and a higher forward P/E. They have kept the overall discount rate broadly in line with prior views.
GMAB
DKK 1,833.00
Genmab
7D
0.4%
1Y
13.3%
BAVA
DKK 196.95
Bavarian Nordic
7D
0.5%
1Y
14.4%

BAVA: Share Buybacks And Latin America Vaccine Deal Will Support Upside

Analysts now keep their DKK 250 price target for Bavarian Nordic intact, as slightly higher discount and future P/E assumptions together with a modestly stronger profit margin view offset softer revenue growth expectations. What's in the News Bavarian Nordic issued earnings guidance for fiscal 2026, indicating expected revenue in the range of DKK 5,000 million to DKK 5,200 million (Corporate guidance).
BIOPOR
DKK 0.93
BioPorto
7D
-3.6%
1Y
-38.2%
STRAP
DKK 624.00
Strategic Partners
7D
-1.9%
1Y
-20.1%